Cholangiocarcinoma
Showing NaN - NaN of 15
Biliary Cell-derived Organoids From Bile of PSC and Non-PSC
Recruiting
- Primary Sclerosing Cholangitis
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 9, 2023
Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester
Active, not recruiting
- Cholangiocarcinoma
- +6 more
- Laboratory Biomarker Analysis
- Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
-
Scottsdale, Arizona
- +1 more
Jan 4, 2023
Prospective Evaluation of Biliary Tissue Sampling With ERCP
Enrolling by invitation
- Cholangiopancreatography, Endoscopic Retrograde
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 7, 2022
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Cholangiocarcinoma Trial in Worldwide (Fimaporfin and Gemcitabine, Gemcitabine/Cisplatin chemo)
Active, not recruiting
- Cholangiocarcinoma
- Fimaporfin and Gemcitabine
- Gemcitabine/Cisplatin chemotherapy
-
Duarte, California
- +49 more
Mar 4, 2022
Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, Cholangiocarcinoma Trial in Rochester
Recruiting
- Primary Sclerosing Cholangitis
- +3 more
-
Rochester, MinnesotaMayo Clinic
Feb 22, 2022
Cholangiocarcinoma Trial in Austria, United States (Nab-Paclitaxel and Gemcitabine)
Completed
- Cholangiocarcinoma
- Nab-Paclitaxel and Gemcitabine
-
Denver, Colorado
- +24 more
Sep 5, 2018
Primary Sclerosing Cholangitis, Trisomy 7, Cholangiocarcinoma Trial in Rochester (Erlotinib (Tarceva))
Completed
- Primary Sclerosing Cholangitis
- +3 more
- Erlotinib (Tarceva)
-
Rochester, MinnesotaMayo Clinic
Jan 9, 2014